Literature DB >> 28082174

Isolation and identification methods of Rothia species in oral cavities.

Osamu Tsuzukibashi1, Satoshi Uchibori2, Taira Kobayashi2, Koji Umezawa3, Chiho Mashimo4, Takayuki Nambu4, Masanori Saito5, Tomomi Hashizume-Takizawa5, Tomoko Ochiai5.   

Abstract

Rothia dentocariosa and Rothia mucilaginosa which are Gram-positive bacteria are part of the normal flora in the human oral cavity and pharynx. Furthermore, Rothia aeria, which was first isolated from air samples in the Russian space station Mir, is predicted to be an oral inhabitant. Immunocompromised patients are often infected by these organisms, leading to various systemic diseases. The involvement of these organisms in oral infections has attracted little attention, and their distribution in the oral cavity has not been fully clarified because of difficulties in accurately identifying these organisms. A suitable selective medium for oral Rothia species, including R. aeria, is necessary to assess the veritable prevalence of these organisms in the oral cavity. To examine the bacterial population in the oral cavity, a novel selective medium (ORSM) was developed for isolating oral Rothia species in this study. ORSM consists of tryptone, sodium gluconate, Lab-Lemco powder, sodium fluoride, neutral acriflavin, lincomycin, colistin, and agar. The average growth recovery of oral Rothia species on ORSM was 96.7% compared with that on BHI-Y agar. Growth of other representative oral bacteria, i.e. genera Streptococcus, Actinomyces, Neisseria, and Corynebacterium, was remarkably inhibited on the selective medium. PCR primers were designed based on partial sequences of the 16S rDNA genes of oral Rothia species. These primers reacted to each organism and did not react to other non-oral Rothia species or representative oral bacteria. These results indicated that these primers are useful for identifying oral Rothia species. A simple multiplex PCR procedure using these primers was a reliable method of identifying oral Rothia species. The proportion of oral Rothia species in saliva samples collected from 20 subjects was examined by culture method using ORSM. Rothia dentocariosa, Rothia mucilaginosa, and R. aeria accounted for 1.3%, 5.9%, and 0.8% of the total cultivable bacteria number on BHI-Y agar in the oral cavities of all subjects, respectively. It was indicated that among oral Rothia species, R. mucilaginosa is most predominant in the oral cavity of humans. A novel selective medium, ORSM, was useful for isolating each oral Rothia species.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genus Rothia; Oral cavity; Selective medium

Mesh:

Substances:

Year:  2017        PMID: 28082174     DOI: 10.1016/j.mimet.2017.01.005

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  17 in total

1.  Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Matthew S Kelly; Doyle V Ward; Christopher J Severyn; Mehreen Arshad; Sarah M Heston; Kirsten Jenkins; Paul L Martin; Lauren McGill; Andre Stokhuyzen; Shakti K Bhattarai; Vanni Bucci; Patrick C Seed
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-18       Impact factor: 5.742

2.  Analysis of culturable microbiota present in the stomach of children with gastric symptoms.

Authors:  Changcheng Guo; Fang Liu; Li Zhu; Fangcao Wu; Guzhen Cui; Yan Xiong; Qiong Wang; Lin Yin; Caixia Wang; Huan Wang; Xiaojuan Wu; Zhengrong Zhang; Zhenghong Chen
Journal:  Braz J Microbiol       Date:  2018-12-19       Impact factor: 2.476

3.  Antimicrobial Peptide GH12 Prevents Dental Caries by Regulating Dental Plaque Microbiota.

Authors:  Wentao Jiang; Yufei Wang; Junyuan Luo; Xiangshu Chen; Yuhao Zeng; Xinwei Li; Zening Feng; Linglin Zhang
Journal:  Appl Environ Microbiol       Date:  2020-07-02       Impact factor: 4.792

4.  Gastro-intestinal and oral microbiome signatures associated with healthy aging.

Authors:  Harinder Singh; Manolito G Torralba; Kelvin J Moncera; Lauren DiLello; Joann Petrini; Karen E Nelson; Rembert Pieper
Journal:  Geroscience       Date:  2019-10-16       Impact factor: 7.713

Review 5.  The pathogenic oral-gut-liver axis: new understandings and clinical implications.

Authors:  Jin Imai; Sho Kitamoto; Nobuhiko Kamada
Journal:  Expert Rev Clin Immunol       Date:  2021-06-08       Impact factor: 5.124

6.  Acetaldehyde production by Rothia mucilaginosa isolates from patients with oral leukoplakia.

Authors:  Abdrazak Amer; Aine Whelan; Nezar N Al-Hebshi; Claire M Healy; Gary P Moran
Journal:  J Oral Microbiol       Date:  2020-03-21       Impact factor: 5.474

7.  Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study.

Authors:  Andreas Blesl; Christoph Jüngst; Frank Lammert; Günter Fauler; Florian Rainer; Bettina Leber; Nicole Feldbacher; Silvia Stromberger; Renate Wildburger; Walter Spindelböck; Peter Fickert; Angela Horvath; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2020-09-07       Impact factor: 5.717

8.  Keystone Species in Pregnancy Gingivitis: A Snapshot of Oral Microbiome During Pregnancy and Postpartum Period.

Authors:  Preethi Balan; Yap Seng Chong; Shivshankar Umashankar; Sanjay Swarup; Wong Mun Loke; Violeta Lopez; Hong Gu He; Chaminda Jayampath Seneviratne
Journal:  Front Microbiol       Date:  2018-10-09       Impact factor: 5.640

9.  First reported case of Rothia dentocariosa spondylodiscitis in an immunocompetent patient.

Authors:  Jean-Marc Schwob; Violène Porto; Sigiriya Aebischer Perone; Christian Van Delden; Gilles Eperon; Alexandra Calmy
Journal:  IDCases       Date:  2019-12-20

10.  Re-initiation of Oral Food Intake Following Enteral Nutrition Alters Oral and Gut Microbiota Communities.

Authors:  Sayaka Katagiri; Takahiko Shiba; Haruka Tohara; Kohei Yamaguchi; Koji Hara; Kazuharu Nakagawa; Keiji Komatsu; Kazuki Watanabe; Yujin Ohsugi; Shogo Maekawa; Takanori Iwata
Journal:  Front Cell Infect Microbiol       Date:  2019-12-20       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.